If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEurocell Regulatory News (ECEL)

Share Price Information for Eurocell (ECEL)

Share Price is delayed by 15 minutes
Get Live Data
112.00    -2.00 (-1.75%)
Bid:
109.00
Ask:
112.50
Spread: 3.50 (3.211%)
Market Cap: £110.38m
ECEL Live PriceLast checked at - London Stock Exchange

Intraday Eurocell Share Chart

Acquisition

9 Mar 2016 07:00

RNS Number : 4738R
Eurocell plc
09 March 2016
 

9 March 2016

 

Eurocell plc

Acquisition of Vista Panels Ltd

 

Eurocell plc ("Eurocell" or the "Company"), the leading sustainable B2B supplier of PVC building products with its own distribution network is pleased to announce it has signed an agreement for the acquisition of Vista Panels Ltd ("Vista") from CorpAcq Limited. The consideration for the acquisition is £7.1m, on a debt free, cash free basis, to be funded from existing bank facilities and is expected to be earnings enhancing in the first full year of ownership.

About Vista

Headquartered in the Wirral, United Kingdom, Vista is a leading manufacturer of composite and PVC-U entrance doors and has been a leader in the growth of the composite doors market in the UK, with a strong presence in the social housing and private RMI sectors. It is currently the sole supplier of entrance doors to Eurocell and a significant consumer of Eurocell's profile products. The Company currently employs over 100 people nationwide. In the year ended 31 December 2015, Vista generated revenue of £13.7m. The earnings before interest and tax were £1.4m and gross assets were £3.9 million.

It is expected that Vista will continue to operate as a standalone business in the Wirral under the Vista brand. The current management team will remain with Vista.

Patrick Bateman, Chief Executive Officer, commented: "The acquisition will broaden the routes to market for Vista in particular to the new build sector, and provide opportunity for cross selling into the respective customer bases. We know the business well, having worked with them both as a customer and a supplier. It's logical, therefore, that we wanted them to join forces with us. Together we have a stronger proposition in markets strategically important to both businesses." 

 

Enquiries:

Teneo Strategy +44 (0) 20 3603 5220

Ben Foster

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQSSEEFAFMSEED
Date   Source Headline
11th Apr 20237:00 amRNSAnnual Financial Report
20th Mar 20237:00 amRNSInvestor Presentation
17th Mar 20237:00 amRNSDirector/PDMR Shareholding
16th Mar 20237:00 amRNSPreliminary results for the year ended 31 Dec 2022
7th Mar 20237:00 amRNSBlock listing Interim Review
3rd Feb 20237:00 amRNSNon-executive Directors' Share Purchase Plan
31st Jan 20237:00 amRNSHolding(s) in Company
26th Jan 20237:00 amRNSYear End Trading Update
6th Jan 20237:00 amRNSCEO Announces Intention to Retire in 2023
15th Nov 20227:04 amRNSHolding(s) in Company
14th Nov 20227:00 amRNSHolding(s) in Company
10th Nov 20224:00 pmRNSHolding(s) in Company
8th Nov 20223:59 pmRNSDirectorate Change
26th Oct 20227:00 amRNSHolding(s) in Company
7th Oct 20227:00 amRNSChanges to Board Committee memberships
5th Oct 20222:00 pmRNSHolding(s) in Company
3rd Oct 20227:00 amRNSTotal Voting Rights
5th Sep 20227:00 amRNSBlock listing Interim Review
5th Sep 20227:00 amRNSInvestor Presentation
1st Sep 20227:00 amRNSHalf-year Report
15th Aug 20223:00 pmRNSHolding(s) in Company
10th Aug 20223:45 pmRNSAppointment to the Audit & Risk Committee
13th Jul 20227:00 amRNSTrading Update
5th Jul 202212:25 pmRNSHolding(s) in Company
1st Jul 20227:00 amRNSTotal Voting Rights
22nd Jun 20227:00 amRNSDirector/PDMR Shareholding
21st Jun 202212:08 pmRNSDirectorate Change
25th May 20227:00 amRNSBlock Listing Application
16th May 20227:00 amRNSDirector/PDMR Shareholding
12th May 20224:00 pmRNSResult of AGM
12th May 20227:00 amRNSAGM Trading Update and Board Update
14th Apr 20224:00 pmRNSDirector/PDMR Shareholding
14th Apr 20224:00 pmRNSDirector/PDMR Shareholding
8th Apr 20227:00 amRNSAnnual Financial Report
21st Mar 20227:00 amRNSInvestor Presentation
18th Mar 20227:00 amRNSPreliminary results for the year ended 31 Dec 2021
17th Mar 20227:00 amRNSNotice of Results and Audiocast
15th Mar 20223:05 pmRNSTransaction in Own Shares
9th Mar 20225:00 pmRNSBlock listing Interim Review
16th Feb 20227:00 amRNSAppointment of Joint Corporate Broker
21st Jan 20227:00 amRNSYear End Trading Update
4th Jan 20227:00 amRNSTotal Voting Rights
1st Dec 20217:00 amRNSTotal Voting Rights
24th Nov 20217:00 amRNSTrading Update November 2021
1st Nov 20217:00 amRNSTotal Voting Rights
1st Oct 20217:00 amRNSTotal Voting Rights
7th Sep 20214:00 pmRNSInvestor Presentation
7th Sep 20211:38 pmRNSBlock listing Interim Review
3rd Sep 20217:00 amRNSHalf-year Report
1st Sep 20217:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.